Holen Sie sich die Stockscreener-App
5.435
4.65%
-0.265
Schlusskurs vom Vortag:
$5.70
Offen:
$5.77
24-Stunden-Volumen:
31,613
Relative Volume:
1.16
Marktkapitalisierung:
$383.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.97M
KGV:
-5.501
EPS:
-0.988
Netto-Cashflow:
$-1.18M
1W Leistung:
-5.64%
1M Leistung:
-25.55%
6M Leistung:
-71.20%
1J Leistung:
+0.00%
1-Tages-Spanne:
$5.20
$5.77
1-Wochen-Bereich:
$5.12
$6.49
52-Wochen-Spanne:
$5.12
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
5.435 | 401.97M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Yd Bio Ltd Aktie (YDES) Neueste Nachrichten
GFL ENVIRONMENTAL INC. (GFL) - MSN
YDES Technical Analysis & Stock Price Forecast - Intellectia AI
YDES SEC FilingsYD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan
Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan
YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan
Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan
YD Bio launches telehealth platform for cancer detection By Investing.com - Investing.com South Africa
YD Bio launches telehealth platform for cancer detection - Investing.com
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - The Manila Times
Yd Bio Limited and Eg Biomed Co., Ltd. Launch Nationwide Telehealth Platform - marketscreener.com
Cancer test platform goes live in 44 states, D.C. and Guam - Stock Titan
YD Bio (YDES) director files Form 3 with no share activity - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
[Form 3] YD Bio Ltd Initial Statement of Beneficial Ownership - Stock Titan
[Form 3] YD Bio Ltd Initial Statement o... - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
YD Bio details roadmap for integrated oncology ecosystem - tipranks.com
YD Bio (YDES) CEO details direct and indirect share stakes - Stock Titan
Collective Metals Initiates Inaugural Drill Program at the Rocas Uranium Project in Southeast Athabasca Basin - The Manila Times
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem - Bitget
Inside YD Bio’s plan to link cancer detection with immunotherapy - Stock Titan
Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen - Defense World
NMFC PE Ratio & Valuation, Is NMFC Overvalued - Intellectia AI
Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen - Defense World
YD Bio (NASDAQ: YDES) registers 11.5M warrant shares; announces Taiwan-U.S. FDA alliance - Stock Titan
YD Bio Forms Taiwan-U.S. Dual-Core FDA Regulatory Platform in Alliance with YC Biotech - TipRanks
YD Bio (Nasdaq: YDES) builds Taiwan-U.S. FDA regulatory platform - Stock Titan
YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform - BioSpectrum Asia
YD Bio Says US Unit Selected as FDA Liaison for YC Biotech's Asia Clients - marketscreener.com
Yd Bio Limited announces strategic partnership with Yc Biotech Co - marketscreener.com
SunPower to Participate in the 38th Annual ROTH Conference - The Manila Times
Rumble App Now Includes Rumble Shorts on iPhones Following Apple Approval - The Manila Times
The Chefs’ Warehouse, Inc. to Participate in the UBS Global Consumer & Retail Conference - The Manila Times
Freshworks to Participate in Upcoming Investor Conferences - The Manila Times
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March - The Manila Times
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference - The Manila Times
Prime Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Major Shareholder Announcement - The Manila Times
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform - marketscreener.com
Inside YD Bio’s new Taiwan‑U.S. gateway for FDA drug and device approvals - Stock Titan
YDESYD Bio Ltd Latest Stock News & Market Updates - Stock Titan
Ethan Shen holds 77.06% of YD Bio Ltd (YDES) as amended ownership filing - Stock Titan
YD Bio Ltd (YDES) PE Ratio (TTM) Chart - GuruFocus
YD Bio Shares Spark Retail Trader Buzz Following Nasdaq Debut via Breeze SPAC - MSN
CMB.TECH to Release Q4 2025 Earnings on February 26, 2026 - Intellectia AI
CMB.TECH Sells Two VLCCs, Realizing $98.2 Million Gain - Intellectia AI
Weekly Buzz: Intellia Gets FDA Nod For ATTRv-PN Trial; Aprea's APR-1051 Paces; CALC Halts KOURAGE - RTTNews
YD Bio Signs Binding LOI to Acquire Taiwan Immunotherapy Firm SSMC - TipRanks
YD Bio to acquire Taiwan’s SSMC for $26.87 million By Investing.com - Investing.com Nigeria
YD Bio to acquire Taiwan’s Safe Save Medical in $26.9 million deal By Investing.com - Investing.com South Africa
Finanzdaten der Yd Bio Ltd-Aktie (YDES)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):